Welcome To Ƶ
China's dimethylformamide (DMF) market finished June under clear downward pressure, with weekly assessments showing a fall of 0.83% in late June as sellers competed to move rising inventories. Early June began with largely stable dimethylformamide quotations, but the market slid through mid-month amid soft buying before settling into a range-bound posture at month-end. Overall sentiment was bearish for June, reflected in a pronounced month-on-month correction, while market participants highlighted monsoon-season demand weakness and cautious downstream procurement as the main near-term headwinds for dimethylformamide trading.
Demand patterns across downstream sectors were uneven. The coatings, adhesives and industrial-solvent segments were notably soft as monsoon slowdowns curtailed typical summer consumption and converters largely bought dimethylformamide on a hand-to-mouth basis, reducing replenishment activity. In contrast, polyurethane and adhesive manufacturers showed signs of moderate support as some players prepared dimethylformamide inventories ahead of an expected seasonal rebound toward September. Pharmaceutical buyers were flagged as a potential upside later in the year, with scenarios wherein stronger API and intermediate buying could prompt forward dimethylformamide purchases and amplify any upward move, according to market notes.
Supply dynamics added to the downward pressure on 徱ٳڴǰ. Several major dimethylformamide facilities resumed production after April maintenance, lifting overall output and contributing to higher inventories at both plant and social-storage levels; per Ƶ data, operating rates ran above 75%, increasing spot availability of dimethylformamide. Feedstock methanol remained broadly stable in June, keeping immediate dimethylformamide production costs steady, yet analysts warned that geopolitical disruptions in Gulf supply routes could tighten spot methanol availability and push opportunity costs higher. A notable maintenance outage at Shaanxi Xinghua Group's Xianyang facility ran through much of June, but the broader restart trend had already eased tightness and supported competitive dimethylformamide selling.
Weekly movement through June showed gradual softening rather than sharp swings in 徱ٳڴǰ: quotations were stable in early June, slipped modestly mid-month, and then declined by 0.83% in late June per weekly assessment data before settling into a narrow range. That pattern fits a market where sellers are offering dimethylformamide material to destock while buyers remain cautious; small week-to-week declines extended a multi-week bearish trend without triggering any abrupt tightness.
Looking ahead, our analysts see downside pressure persisting near term, with 徱ٳڴǰ anticipated to decrease further in July based on current market trends. Key drivers include continued monsoon-season weakness in coatings and adhesives, conservative dimethylformamide procurement amid geopolitical uncertainty, and the risk that improved methanol availability keeps production economics favourable to sellers. Conversely, seasonal restocking around Golden Week or stronger pharmaceutical buying could provide temporary support for dimethylformamide markets.
We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site or by closing this box, you consent to our use of cookies. More info.

Leave a Comment
Comments (0)